Ovarian Cancer Clinical Trial
Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer
The purpose of this study is to learn more about the factors that influence decision-making before surgery (distress about cancer and/or reproductive concerns) and the possibility of regret after surgery.
Women aged ≥ 18 and ≤ 50 years
Endometrioid histological diagnosis
Scheduled for surgical intervention at MSKCC
FIGO grade 1-2, clinical stage I
Disease confined to uterus, no clear evidence of deep (≥50%) myoinvasion on imaging (MRI preferred, ultrasound optional)
Normal ovaries on preoperative imaging
Able to provide informed consent
Known Lynch syndrome
Prior bilateral oophorectomy
Personal history of hormone receptor-positive breast carcinoma
Increased risk of ovarian cancer identified on the basis of family or personal history
Women currently on hormonal contraception, letrozole, or tamoxifen may not opt-in to AMH
Women who recently underwent ovarian stimulation within the past 3 months may not opt-in to AMH
Women who have pituitary dysfunction (or any pituitary disorders) may not opt-in to AMH
Women who completed chemotherapy within <12 months may not opt-in to AMH
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 8 Locations for this study
Hartford Connecticut, 06102, United States More Info
Basking Ridge New Jersey, 07920, United States More Info
Middletown New Jersey, 07748, United States More Info
Montvale New Jersey, 07645, United States More Info
Commack New York, 11725, United States More Info
Harrison New York, 10604, United States More Info
New York New York, 10065, United States More Info
Rockville Centre New York, 11553, United States More Info
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.